PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEnquest Regulatory News (ENQ)

Share Price Information for Enquest (ENQ)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 15.58
Bid: 15.58
Ask: 15.74
Change: -0.06 (-0.38%)
Spread: 0.16 (1.027%)
Open: 14.98
High: 15.82
Low: 14.98
Prev. Close: 15.64
ENQ Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of EnQuest plc's Noteholders meeting

5 May 2015 13:08

RNS Number : 2069M
EnQuest PLC
05 May 2015
 



RESULT OF CONSENT SOLICITATION IN RESPECT OF ENQUEST PLC's£155,000,000 5.50 PER CENT. NOTES DUE 2022

NOT FOR DISTRIBUTION, DIRECTLY OR INDIRECTLY, TO, OR FOR THE ACCOUNT OR BENEFIT OF, U.S. PERSONS (AS SUCH TERM IS DEFINED IN REGULATION S UNDER THE U.S. SECURITIES ACT OF 1933 AS AMENDED) OR IN OR INTO THE UNITED STATES (INCLUDING ITS TERRITORIES AND POSSESSIONS, ANY STATE OF THE UNITED STATES AND THE DISTRICT OF COLUMBIA) OR ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO DISTRIBUTE THE CONSENT SOLICITATION MEMORANDUM (AS DEFINED BELOW).

IF YOU ARE IN ANY DOUBT AS TO THE ACTION YOU SHOULD TAKE, YOU ARE RECOMMENDED TO SEEK YOUR OWN FINANCIAL ADVICE, INCLUDING IN RESPECT OF ANY TAX CONSEQUENCES, IMMEDIATELY FROM YOUR STOCKBROKER, BANK MANAGER, SOLICITOR, ACCOUNTANT OR OTHER INDEPENDENT FINANCIAL ADVISER AUTHORISED UNDER THE FINANCIAL SERVICES AND MARKETS ACT 2000 AS AMENDED (IF YOU ARE IN THE UNITED KINGDOM) OR FROM ANOTHER APPROPRIATELY AUTHORISED INDEPENDENT FINANCIAL ADVISER (IF YOU ARE NOT).

5 May 2015

On 10 April 2015, EnQuest PLC (the "Company") announced that it was inviting holders ("Noteholders") of its outstanding £155,000,000 5.50 per cent. Notes due 15 February 2022 (the "Notes") (ISIN: XS0880578728, Common Code: 088057872) issued pursuant to its £500,000,000 Euro Medium Term Note Programme to consent to certain modifications to the terms and conditions of the Notes (the "Conditions") and the trust deed dated 24 January 2013 as amended and supplemented from time to time (the "Trust Deed") between the Company and U.S. Bank Trustees Limited (the "Trustee") constituting the Notes (such invitation, the "Consent Solicitation"), as further detailed in a consent solicitation memorandum dated 10 April 2015 (the "Consent Solicitation Memorandum").

RESULT OF THE CONSENT SOLICITATION

Further to the Company's announcement of 10 April 2015, NOTICE IS HEREBY GIVEN to the Noteholders that, at the Meeting of Noteholders held at the offices of Ashurst LLP, Broadwalk House, 5 Appold Street, London EC2A 2HA, United Kingdom on 5 May 2015, the Extraordinary Resolution set out in the Notice of Meeting was duly passed and the Supplemental Trust Deed has been duly executed.

In connection with the successful completion of the Consent Solicitation, the Company's CEO Amjad Bseisu said:

"We are very pleased that the proposals have been approved by the Noteholders and that 99.8 per cent. of the votes cast were in favour of the Proposals. This is a prudent and precautionary step to provide us with the flexibility to complete the capital expenditure programme that will significantly enhance the Group's production and cash flow."

The Consent Solicitation was made on the terms and subject to the conditions contained in the Consent Solicitation Memorandum. Capitalised terms used but not otherwise defined in this announcement shall have the meaning given to them in the Consent Solicitation Memorandum.

CONSENT FEE

Noteholders who voted in favour of the Extraordinary Resolution by delivering or procuring the delivery of a Consent Instruction (which was not validly revoked) before the Voting Deadline are eligible to receive a Consent Fee of 0.20 per cent. of the aggregate principal amount of Notes which were the subject of such Consent Instruction.

The Consent Fee will be paid by the Company in one instalment by no later than 19 May 2015 on the terms set out in the Consent Solicitation Memorandum relating to the Consent Solicitation.

CONTACT INFORMATION

Investor enquiries in relation to the Consent Solicitation should be directed to the Company's Financial Advisers:

Evercore Partners International LLP15, Stanhope GateLondon W1K 1LN

E-mail: swag.ganguly@evercore.comTelephone: +44 (0)20 7653 6199

Numis Securities Limited10 Paternoster SquareLondon EC4M 7LT

E-mail: m.dyson@numis.comTelephone: +44 (0)20 7260 1351

Media enquiries should be directed to Bell Pottinger:

Telephone: +44 (0)20 3772 2500Attention: Victoria Geoghegan Nick Lambert Duncan Mayall

DISCLAIMER AND CONSENT SOLICITATION RESTRICTIONS

Evercore Partners International LLP ("Evercore") and Numis Securities Limited ("Numis"), each of which is authorised and regulated in the United Kingdom by the Financial Conduct Authority, are acting as financial advisors to the Company and no-one else in connection with the Consent Solicitation and the other matters referred to in this announcement. Evercore and Numis will not regard any person other than the Company as their client in relation to the Consent Solicitation and the other matters referred to in this announcement and will not be responsible to anyone other than the Company for providing the protections afforded to clients of Evercore or Numis (as the case may be) or for providing advice in relation to the Consent Solicitation or the other matters referred to in this announcement.

The distribution of the Consent Solicitation Memorandum and this announcement in certain jurisdictions may be restricted by law. Persons into whose possession the Consent Solicitation Memorandum or this announcement comes must inform themselves about and observe any such restrictions.

This announcement is given by: EnQuest PLC

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
EGMLLFIFERIEIIE
Date   Source Headline
25th May 20174:39 pmRNSResult of AGM
25th May 20177:00 amRNSOperational Update
15th May 20174:02 pmRNSPublication of a Prospectus
25th Apr 201711:20 amRNSDirector/PDMR Shareholding
19th Apr 20174:10 pmRNSNotice of AGM and Report & Accounts
21st Mar 20174:33 pmRNSHolding(s) in Company
21st Mar 20177:00 amRNSEnQuest PLC Preliminary Results
17th Feb 20177:00 amRNSKraken FPSO in the field and hooked up
30th Jan 201712:44 pmRNSNotice to holders of the Company's Retail Notes
26th Jan 201712:29 pmRNSDirector/PDMR Shareholding
24th Jan 20177:01 amRNSTrading and Operations Update
24th Jan 20177:00 amRNSACQUISITION OF 25% OF MAGNUS OIL FIELD
15th Dec 20167:00 amRNSBoard Appointments
24th Nov 20164:34 pmRNSDirector/PDMR Shareholding
23rd Nov 201612:35 pmRNSHolding(s) in Company
22nd Nov 20163:11 pmRNSDirector/PDMR Shareholding
22nd Nov 201612:10 pmRNSHolding(s) in Company
21st Nov 20164:46 pmRNSHolding(s) in Company
21st Nov 20163:26 pmRNSHolding(s) in Company
21st Nov 20169:08 amRNSCompletion of the financial restructuring
21st Nov 20168:00 amRNSAdmission of New Ordinary Shares
21st Nov 20167:00 amRNSScolty/Crathes First Oil
21st Nov 20167:00 amRNSProduction and development update
18th Nov 201610:27 amRNSConfirmation of Ch 15 Recognition Order-Correction
18th Nov 20167:00 amRNSConfirmation of Chapter 15 Recognition Order
17th Nov 20167:00 amRNSResults of the Placing and Open Offer
16th Nov 20163:43 pmRNSConfirmation of sanction of Scheme of Arrangement
15th Nov 20164:08 pmRNSNotice of Scheme Sanction Hearing
15th Nov 20164:04 pmRNSScheme meeting results correction
14th Nov 20162:40 pmRNSScheme Meeting Results
14th Nov 20161:30 pmRNSResults of General Meeting
31st Oct 20167:00 amRNSEnQuest's Kraken FPSO vessel update
28th Oct 201610:32 amRNSDirector/PDMR Shareholding
26th Oct 20166:28 pmRNSNotice of Chapter 15 Recognition Hearing
24th Oct 20162:21 pmRNSNotice of Scheme Meeting
21st Oct 20163:39 pmRNSNotice of Scheme Convening Hearing
14th Oct 20165:17 pmRNSPublication of a Prospectus
13th Oct 20165:01 pmRNSResult of Equity Issue
13th Oct 201612:25 pmRNSCapital Reorganisation
13th Oct 201612:22 pmRNSIssue of Equity
13th Oct 201612:12 pmRNSPractice Statement Letter
13th Oct 20167:28 amRNSPractice Statement Letter
13th Oct 20167:17 amRNSCapital Reorganisation
13th Oct 20167:00 amRNSIssue of Equity
3rd Oct 201611:01 amRNSHolding(s) in Company
15th Sep 20167:00 amRNSUpdate on potential farm out
8th Sep 20167:02 amRNSDirectorate Change
8th Sep 20167:00 amRNSHalf-year Report
23rd Aug 20169:10 amRNSHolding(s) in Company
16th Aug 201610:02 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.